John J. Duncan, Jr. sold Provectus Biopharmaceuticals Inc (OTCQB: PVCT)
John J. Duncan, Jr. (R-TN), a U.S. Representative, has disclosed 1 trade in Provectus Biopharmaceuticals Inc (PVCT) since 2012, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: John J. Duncan, Jr. sold $1,000 - $15,000 of Provectus Biopharmaceuticals Inc (OTCQB: PVCT) on August 14, 2012. Since that trade, PVCT is down -90.61% against the S&P 500 up +578.58%, an outperformance of -669.19%.
Data updated
John J. Duncan, Jr.'s PVCT trades vs the price
PVCT is down -90.61% since John J. Duncan, Jr. sold on August 14, 2012, versus +578.58% for the S&P 500.
Performance since this trade
All John J. Duncan, Jr. PVCT trades
John J. Duncan, Jr. & PVCT trading FAQ
Is it legal for John J. Duncan, Jr. to trade Provectus Biopharmaceuticals Inc (PVCT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Provectus Biopharmaceuticals Inc (PVCT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did John J. Duncan, Jr. sell PVCT?
John J. Duncan, Jr. disclosed a sale of $1,000 - $15,000 of Provectus Biopharmaceuticals Inc (PVCT) on August 14, 2012, according to public STOCK Act filings.
How has PVCT performed since John J. Duncan, Jr.'s trade?
Since John J. Duncan, Jr. sold PVCT on August 14, 2012, the stock is down -90.61%, versus +578.58% for the S&P 500 over the same period, an outperformance of -669.19%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional PVCT trades?
BullishWhales tracks every disclosed congressional trade in Provectus Biopharmaceuticals Inc (PVCT) on the Provectus Biopharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
John J. Duncan, Jr.'s PVCT tradesAll congressional filings for Provectus Biopharmaceuticals IncJohn J. Duncan, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.